Synapse - Gynecologic Medicine Service

Results (2180)

HLA class I subtypes are associated with immune-related adverse events in patients with melanoma treated with ipilimumab

Meeting Abstract

Safonov, A.; Pluta, J.; Qian, L.; Amaravadi, R.; Applegate, A.; Buchbinder, E.; Cohen, J.; Friedman, C.; Halaban, R.; Hodi, F. S.; more...
Journal for ImmunoTherapy of Cancer (2018)

Fulltext@MSK | Save

Intestinal microbiota composition prior to CAR T cell infusion correlates with efficacy and toxicity

Meeting Abstract

Smith, M.; Littmann, E. R.; Slingerland, J. B.; Clurman, A.; Slingerland, A. E.; Taur, Y.; Schluter, J.; Park, J. H.; O'Cearbhaill, R.; Mailankody, S.; more...
Blood (2018)

Fulltext@MSK | Save

Maintenance olaparib following platinum-based chemotherapy in newly diagnosed patients (pts) with advanced ovarian cancer (OC) and a BRCA1/2 mutation (BRCAm): Phase III SOLO1 trial

Meeting Abstract

Friedlander, M.; Moore, K.; Colombo, N.; Scambia, G.; Kim, B. G.; Oaknin, A.; Lisyanskaya, A.; Floquet, A.; Leary, A.; Sonke, G. S.; more...
Annals of Oncology (2018)

Fulltext@MSK | Save

Maintenance olaparib in patients with newly diagnosed advanced ovarian cancer

Journal Article

Moore, K.; Colombo, N.; Scambia, G.; Kim, B. G.; Oaknin, A.; Friedlander, M.; Lisyanskaya, A.; Floquet, A.; Leary, A.; Sonke, G. S.; more...
New England Journal of Medicine (2018)

Fulltext@MSK | Save

Ado-trastuzumab emtansine (T-DM1) in patients (pts) with HER2 amplified (amp) tumors excluding breast and gastric/gastro-esophageal junction (GEJ) adenocarcinomas: Results from the National Cancer Institute (NCI) Molecular Analysis for Therapy Choice (MATCH) trial

Meeting Abstract

Jhaveri, K. L.; Makker, V.; Wang, X. V.; Chen, A. P.; Flaherty, K.; Conley, B. A.; O'Dwyer, P. J.; Williams, P. M.; Hamilton, S. R.; Harris, L.; more...
Journal of Clinical Oncology (2018)

Fulltext@MSK | Save

Safety and tolerability of adjuvant enzalutamide for the treatment of early stage androgen receptor positive (AR+) triple negative breast cancer

Meeting Abstract

Lyons, T.; Gucalp, A.; Arumov, A.; Patil, S.; Edelweiss, M.; Gorsky, M.; Troso-Sandoval, T. A.; Bromberg, J.; Sanford, R. A.; Iyengar, N. M.; more...
Journal of Clinical Oncology (2018)

Fulltext@MSK | Save

The Memorial Sloan Kettering (MSK) electronic informed consent (eIC) platform for clinical trials: An operational model and suite of tools for obtaining informed consent, and managing consent documents

Meeting Abstract

Buckley, M. T.; Lengfellner, J. M.; Koch, M. J.; Pacheco, H. O.; Hoidra, C.; Damron, D. J.; Cambria, R.; Rodavitch, A.; Sabbatini, P.
Journal of Clinical Oncology (2018)

Fulltext@MSK | Save

Phase Ib study of binimetinib with paclitaxel in patients with platinum-resistant ovarian cancer: Final results, potential biomarkers, and extreme responders

Journal Article

Grisham, R. N.; Moore, K. N.; Gordon, M. S.; Harb, W.; Cody, G.; Halpenny, D. F.; Makker, V.; Aghajanian, C. A.
Clinical Cancer Research (2018)

Fulltext@MSK | Save

A phase II evaluation of elesclomol sodium and weekly paclitaxel in the treatment of recurrent or persistent platinum-resistant ovarian, fallopian tube or primary peritoneal cancer: An NRG Oncology/Gynecologic Oncology Group study

Journal Article

Monk, B. J.; Kauderer, J. T.; Moxley, K. M.; Bonebrake, A. J.; Dewdney, S. B.; Secord, A. A.; Ueland, F. R.; Johnston, C. M.; Aghajanian, C.
Gynecologic Oncology (2018)

Fulltext@MSK | Save

It's time to warm up to hyperthermic intraperitoneal chemotherapy for patients with ovarian cancer

Journal Article

Zivanovic, O.; Chi, D. S.; Filippova, O.; Randall, L. M.; Bristow, R. E.; O'Cearbhaill, R. E.
Gynecologic Oncology (2018)

Fulltext@MSK | Save